FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Hegseth Takes House Dem to the Woodshed for Pushing Iranian ‘Propaganda’ at Hearing: ‘Shame on You!’

Minnesota ‘tried to cover up fraud allegations,’ former state trooper alleges

Class and Decency: Watch Johnny Carson Address Reagan Assassination Attempt the Day After It Happened

Bodycam shows dad bolt from cops with young child in his arms before ditching her alone in the woods

Trump DOJ report lays bare Biden administration’s alleged anti-Christian bias

WATCH: Chaos erupts as Florida Dem in pink jumpsuit grabs bullhorn mid-vote: ‘It’s illegal!’

Dem Rep Who Resigned in Disgrace Over Federal Charges Quietly Made Move to Run Again Before Quitting: Reports

David Allan Coe, Outlaw Country Legend Behind ‘Take This Job and Shove It,’ Dies at 86

Biden IRS discriminated against Christian groups, DOJ report finds

Federal appeals court refuses to rehear Trump appeal of $83M E Jean Carroll defamation judgment

Hunter Biden’s ex-lawyer ordered to pay $50K to former Trump aide after harassment claims crumble

Graham urges Trump to ‘ignore’ war powers deadline as GOP grapples with Iran

Cultural groups ask federal judge to halt Trump’s renovations of Kennedy Center

Georgia man says he suffered severe medical neglect leading to amputations at scrutinized Atlanta jail

LAPD chief warns Los Angeles not prepared to secure 2028 Olympics due to staffing shortages

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”